These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6348018)

  • 21. Ceftazidime in cystic fibrosis: pharmacokinetics and therapeutic response.
    Kercsmar CM; Stern RC; Reed MD; Myers CM; Murdell D; Blumer JL
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():289-95. PubMed ID: 6352634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and tissue penetration of ceftazidime: studies on lymph, aqueous humour, skin blister, cerebrospinal and pleural fluid.
    Walstad RA; Hellum KB; Blika S; Dale LG; Fredriksen T; Myhre KI; Spencer GR
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():275-82. PubMed ID: 6352632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of the third-generation cephalosporins.
    Harding SM
    Am J Med; 1985 Aug; 79(2A):21-4. PubMed ID: 4025382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacokinetic studies on ceftazidime in the obstetrical and gynecological field].
    Ito K; Kondo H; Hayasaki M; Noda K
    Jpn J Antibiot; 1984 Jan; 37(1):18-22. PubMed ID: 6374194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of cefroxadine in healthy volunteers and patients with impaired renal function.
    Ohkawa M; Takamae K; Shimamura M; Kuroda K; Awazu S
    Chemotherapy; 1981; 27(3):149-54. PubMed ID: 7226971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase 1 Study Assessing the Pharmacokinetic Profile and Safety of Avibactam in Patients With Renal Impairment.
    Merdjan H; Tarral A; Das S; Li J
    J Clin Pharmacol; 2017 Feb; 57(2):211-218. PubMed ID: 27402250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis.
    Strandvik B; Malmborg AS; Alfredson H; Ericsson A
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():283-7. PubMed ID: 6352633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [On the behavior of phenols and creatinine in renal insufficiency, especilly in chronic dialysis patients].
    Jutzler GA; Kramer HJ; Keller HE; Kramer H; Doenecke F
    Arch Klin Med; 1968; 214(3):214-43. PubMed ID: 5683859
    [No Abstract]   [Full Text] [Related]  

  • 29. The kinetics of CAZ-5, a novel SHV-related plasmid-mediated beta-lactamase with enhanced hydrolytic activity against ceftazidime.
    Labia R; Thabaut A; Morand A; Tiwari K; Sirot D; Sirot J
    Drugs Exp Clin Res; 1989; 15(11-12):535-40. PubMed ID: 2700319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of moxalactam in patients with normal and impaired renal function.
    Aronoff GR; Sloan RS; Luft FC
    J Infect Dis; 1982 Mar; 145(3):365-9. PubMed ID: 6460824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
    Smith BR
    Clin Pharm; 1984; 3(4):373-85. PubMed ID: 6380902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ceftazidime in clinical practice - a summary.
    Norrby SR
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():405-8. PubMed ID: 6352652
    [No Abstract]   [Full Text] [Related]  

  • 33. Ceftazidime disposition in acute and stable cystic fibrosis.
    Leeder JS; Spino M; Isles AF; Tesoro AM; Gold R; MacLeod SM
    Clin Pharmacol Ther; 1984 Sep; 36(3):355-62. PubMed ID: 6432400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacokinetics of trometamol-fosfomycin in patients with renal insufficiency].
    Fillastre JP; Leroy A; Josse S; Moulin B
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):728-30. PubMed ID: 3054756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic properties of the newer cephalosporins. A valid basis for drug selection?
    Noble JT; Barza M
    Drugs; 1985 Sep; 30(3):175-81. PubMed ID: 3899596
    [No Abstract]   [Full Text] [Related]  

  • 36. Human pharmacokinetics of cephalexin.
    Bergan T; Midtvedt T; Erikssen J
    Pharmacology; 1970; 4(5):264-72. PubMed ID: 5490473
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacokinetics and metabolism of the cephalosporins].
    Graninger W
    Wien Klin Wochenschr Suppl; 1983; 142():11-5. PubMed ID: 6580781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cephalexin in patients with renal disease.
    Linquist JA; Siddiqui JY; Smith IM
    N Engl J Med; 1970 Oct; 283(14):720-3. PubMed ID: 5454765
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical pharmacology of ceftazidime in paediatrics.
    Assael BM; Boccazzi A; Caccamo ML; Giunta A; Marini A; Padoan R; Rusconi F; Sereni F
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():341-6. PubMed ID: 6352640
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics of low dose sulfadiazine in patients with renal failure.
    Seppänen J; Viranta M; Julkunen R; Wilén G
    Ann Clin Res; 1980; (25):31-7. PubMed ID: 7377747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.